-
Successful FDA inspection at Aurisco
Aurisco Pharmaceutical today announced that its manufacturing site in Badu, Tiantai has successfully passed a USFDA cGMP inspection, which lasted for 5 days , from March 17 to March 21,2025. The inspection conclusion is NAI (No Action Indicated).
-
Brazil President Met Aurisco Chairman
On May 12, 2025, Luiz Inácio Lula da Silva, President of the Federative Republic of Brazil, met with Peng Zhien, Chairman of Aurisco in Beijing.
-
Joint AI Oligonucleotide Drugs Lab Established
East China Normal University and Aurisco Pharmaceutical Co., Ltd. jointly inaugurated AI-Driven Oligonucleotide Drugs Discovery Laboratory. The signing and inauguration ceremony of the AI-Driven Oligonucleotide Drugs Discovery Joint Laboratory was held at East China Normal University's Putuo Campus.
-
Aurisco was awarded a GOLD medal by EcoVadis.
Aurisco achieved a score of 78 in the 2024 EcoVadis Corporate Social Responsibility Rating and was awarded a GOLD medal by EcoVadis.
-
FlexFactory for Oligonucleotide launched
Aurisco's first oligonucleotide commercial manufacturing line was successfully delivered by Cytiva, accelerating the commercialization process of oligonucleotide drugs.
Follow Aoruite WeChat official account